Statins and Risk of Myocardial Infarction in Real Life in France

NCT ID: NCT00679575

Last Updated: 2010-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

13171 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-03-31

Study Completion Date

2010-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this case-referent study is to assess the impact of statins usage on the risk of having a first myocardial infarction (MI) in a real life situation in France

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myocardial Infarction

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

statins myocardial infarction case-referent study France

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Cases : Patients with a first myocardial infarction

No interventions assigned to this group

2

Referents : Patients recruited by a GP during a routine consultation

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients can speak French or English
* Patients can be interviewed by telephone
* Place of usual residence in the area of recruitment

Exclusion Criteria

* Patients refusing to participate in the study
* Patients who cannot be reached by telephone
* Previous history of myocardial infarction
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

AstraZeneca

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lucien Abenhaim

Role: STUDY_CHAIR

LA-SER29, rue du Faubourg Saint-Jacques75014 Paris

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Ambilly, , France

Site Status

Research Site

Angers, , France

Site Status

Research Site

Arles, , France

Site Status

Research Site

Bagnols-sur-Cèze, , France

Site Status

Research Site

Bayonne, , France

Site Status

Research Site

Béziers, , France

Site Status

Research Site

Boulogne-sur-Mer, , France

Site Status

Research Site

Bourgoin, , France

Site Status

Research Site

Bron, , France

Site Status

Research Site

Cambo-les-Bains, , France

Site Status

Research Site

Cenon, , France

Site Status

Research Site

Châteauroux, , France

Site Status

Research Site

Clermont-Ferrand, , France

Site Status

Research Site

Colmar, , France

Site Status

Research Site

Crest, , France

Site Status

Research Site

Dijon, , France

Site Status

Research Site

Draguignan, , France

Site Status

Research Site

Eaubonne, , France

Site Status

Research Site

Firminy, , France

Site Status

Research Site

Forbach, , France

Site Status

Research Site

Fréjus, , France

Site Status

Research Site

Gleizé, , France

Site Status

Research Site

Grasse, , France

Site Status

Research Site

Guéret, , France

Site Status

Research Site

La Rochelle, , France

Site Status

Research Site

Langres, , France

Site Status

Research Site

Laon, , France

Site Status

Research Site

Le Coudray, , France

Site Status

Research Site

Le Mans, , France

Site Status

Research Site

Le Puy-en-Velay, , France

Site Status

Research Site

Mayenne, , France

Site Status

Research Site

Millau, , France

Site Status

Research Site

Montélimar, , France

Site Status

Research Site

Montfermeil, , France

Site Status

Research Site

Montpellier, , France

Site Status

Research Site

Nîmes, , France

Site Status

Research Site

Orange, , France

Site Status

Research Site

Orléans, , France

Site Status

Research Site

Paris, , France

Site Status

Research Site

Pau, , France

Site Status

Research Site

Perpignan, , France

Site Status

Research Site

Puilboreau, , France

Site Status

Research Site

Rueil-Malmaison, , France

Site Status

Research Site

Rumilly, , France

Site Status

Research Site

Saint Amand Monrond, , France

Site Status

Research Site

Saint Jean Des Verges, , France

Site Status

Research Site

Saint-Estève, , France

Site Status

Research Site

Sallanches, , France

Site Status

Research Site

Salon-de-Provence, , France

Site Status

Research Site

Sens, , France

Site Status

Research Site

Thonon-les-Bains, , France

Site Status

Research Site

Toulouse, , France

Site Status

Research Site

Tours, , France

Site Status

Research Site

Tulles, , France

Site Status

Research Site

Valence, , France

Site Status

Research Site

Villefranche-de-Rouergue, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-CFR-CRE-2007/1

Identifier Type: -

Identifier Source: org_study_id